Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?

If you've been looking into medically guided weight loss, you've probably come across two names more than any others: semaglutide and tirzepatide. Both belong to a class of medications called GLP-1 receptor agonists. Both have shown impressive results in clinical trials. And both are now widely available through telehealth providers.

So which one is better? The honest answer: it depends. But this guide will walk you through the real differences so you can have a more informed conversation with your provider.

What are GLP-1 medications?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals your brain that you're full, slows digestion, and helps regulate blood sugar. GLP-1 receptor agonists mimic this hormone — and do it more consistently and powerfully than your body does on its own.

The result: reduced appetite, better portion control, and for many people, meaningful and sustained weight loss.

Semaglutide: the first major GLP-1 success story

Semaglutide (brand names Ozempic and Wegovy) was originally developed to treat Type 2 diabetes. Researchers noticed patients consistently lost weight on it — not as a side effect, but as a primary outcome. The STEP clinical trials confirmed it: people taking semaglutide for weight loss lost an average of 15% of their body weight over 68 weeks.

Semaglutide works by activating GLP-1 receptors, which slows gastric emptying and reduces appetite. It's taken once weekly via subcutaneous injection. Most people start at a low dose and titrate up gradually to minimize side effects.

Tirzepatide: the dual-action newcomer

Tirzepatide (brand names Mounjaro and Zepbound) was approved more recently and takes a different approach. It's a dual agonist — it activates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is another gut hormone involved in appetite regulation, fat metabolism, and insulin response.

The SURMOUNT trials showed tirzepatide produced average weight loss of up to 22.5% of body weight at the highest dose — results that rival bariatric surgery in some comparisons. It's also taken as a once-weekly injection.

Head-to-head: the key differences

Here's how the two medications compare across the dimensions most patients care about:

Mechanism of action

Semaglutide targets a single receptor (GLP-1). Tirzepatide targets two (GLP-1 and GIP). Whether that dual action translates to meaningfully better outcomes for any given person is still being studied, but the clinical data so far suggests tirzepatide produces greater average weight loss.

Weight loss results

In clinical trials, tirzepatide generally outperformed semaglutide in terms of total body weight reduction. However, averages can be misleading. Some people respond exceptionally well to semaglutide. Individual response varies based on genetics, lifestyle, starting weight, and other health factors.

Side effects

Both medications share a similar side effect profile: nausea, constipation, diarrhea, and occasional vomiting — especially early on or after a dose increase. These typically improve over time. Starting low and titrating slowly is the standard approach, and it works well for most people.

Some people tolerate one medication better than the other. This is genuinely individual. There's no way to predict in advance — which is one reason having an ongoing relationship with a provider matters.

Cost and access

Brand-name versions of both medications can be expensive without insurance coverage. Compounded versions of both semaglutide and tirzepatide are available through FDA-registered pharmacies and offer a more accessible price point for many patients — which is why telehealth providers like SailRx work with compounding pharmacies.

So which one is right for you?

This is exactly the question your provider is there to help answer. But here's a general framework:

• If you want the medication with the longest track record and robust long-term data, semaglutide has been studied more extensively over time.
• If you have a larger amount of weight to lose and want the option with the highest average efficacy in trials, tirzepatide may be worth discussing.
• If you've tried one and didn't respond well or experienced difficult side effects, switching to the other is a reasonable next step.
• If cost is a primary concern, both are available in compounded form — your provider can discuss current pricing.

The bottom line

Both semaglutide and tirzepatide are genuinely effective medications. They've helped thousands of people lose weight, improve their metabolic health, and feel better in their bodies. The "best" one is the one that works for you — and figuring that out is a conversation, not a Google search.

At SailRx, every patient gets a licensed provider review before any treatment begins. We look at your health history, your goals, and what matters to you — then we work together to find the right fit. You don't have to come in with the answer already decided.

You don't need to have all the answers before you start. That's what your provider is for.

This article is for general educational purposes only and is not medical advice. It does not replace a consultation with a licensed healthcare provider, who will determine whether any treatment is appropriate for you. Compounded medications are not FDA-approved. How we write our articles.